Effect of Ki-67 on Immunohistochemical Classification of Luminal A to Luminal B Subtypes of Breast Carcinoma.

about

The Impact of Ki-67 on Immunostaining in Classification of Luminal Subtypes of breast Cancer.

P2860

Q46392750-2C1949F7-37DB-46B6-83DF-61317FC9A6C6

P2860

Effect of Ki-67 on Immunohistochemical Classification of Luminal A to Luminal B Subtypes of Breast Carcinoma.

Item

http://www.wikidata.org/entity/Q40772739

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Effect of Ki-67 on Immunohisto ...... Subtypes of Breast Carcinoma.

@en

type

Item

label

Effect of Ki-67 on Immunohisto ...... Subtypes of Breast Carcinoma.

@en

prefLabel

Effect of Ki-67 on Immunohisto ...... Subtypes of Breast Carcinoma.

@en

P1476

Effect of Ki-67 on Immunohisto ...... Subtypes of Breast Carcinoma.

@en

P2093

Leonardo Ribeiro Soares

http://www.w3.org/2001/XMLSchema#string

Magno Belém Cirqueira

http://www.w3.org/2001/XMLSchema#string

Maria-Auxiliadora de Paula Carneiro Cysneiros

http://www.w3.org/2001/XMLSchema#string

Maria-Helena Tavares Vilela

http://www.w3.org/2001/XMLSchema#string

Marise Amaral Rebouças Moreira

http://www.w3.org/2001/XMLSchema#string

P2860

The Measurement of Observer Agreement for Categorical Data

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes

Geographic differences in the distribution of molecular subtypes of breast cancer in Brazil

Molecular breast cancer subtypes and therapies in a public hospital of northeastern Brazil.

P304

465-472

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/TBJ.12441

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ruffo Freitas-Junior

P577

2015-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

279728101

http://www.w3.org/2001/XMLSchema#string

P698

26138552

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

Effect of Ki-67 on Immunohistochemical Classification of Luminal A to Luminal B Subtypes of Breast Carcinoma.

about

P2860

P2860

Effect of Ki-67 on Immunohistochemical Classification of Luminal A to Luminal B Subtypes of Breast Carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921